NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy pathways. Natural NAD+ levels decline with age, and NAD+ is studied for its role in longevity-related pathways. Human data is still emerging. Available by prescription only after provider review.
From $188 first month
What this coenzyme does at the cellular level.
NAD+ is a coenzyme involved in cellular energy pathways. Cells use NAD+ in the reactions that convert nutrients into usable cellular energy.
NAD+ is involved in the activity of sirtuins and PARP enzymes, protein families studied for their roles in cellular maintenance and DNA-damage response pathways.
Natural NAD+ levels decline with age in human studies, and researchers are studying what NAD+ supplementation may mean for age-related pathways. Human data is still emerging.
A subcutaneous injection option for patients who prefer an injectable format over oral capsules or nasal sprays.
A provider-reviewed NAD+ protocol, prescribed online when appropriate.
A subcutaneous injection typically taken 2 to 3 times weekly at home, as directed by your provider.
Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.
Compounded by a licensed U.S. pharmacy and shipped to your door in discreet packaging with free shipping.
Message your care team anytime. Dose adjustments and refills are handled online.
NAD+ is a coenzyme involved in cellular energy pathways, and its levels decline with age.
Get started in 4 simple steps. No office visits required.
A 5-minute online health questionnaire, no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose adjustments and refills handled online.
Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.
Start Assessment
Injection, capsule, or troche. A GHRH peptide option available in multiple formats when prescribed by a provider.
Subcutaneous injection. An injectable glutathione option for patients who prefer an injectable format over capsules or tablets.
Weekly oral protocol. Provider-supervised rapamycin when prescribed after provider review.